Literature DB >> 17539897

Constitutive deficiency in DNA mismatch repair.

K E A Felton1, D M Gilchrist, S E Andrew.   

Abstract

Mutations in the DNA mismatch repair (MMR) genes are associated with the inheritance of hereditary non-polyposis colorectal cancer, also known as Lynch syndrome, a cancer syndrome with an average age at onset of 44. Individuals presenting with colorectal cancer are diagnosed with Lynch I, whereas individuals who present with extra-colonic tumors (such as endometrial, stomach, etc.) are identified as patients with Lynch syndrome II. Recently, 30 families have been reported with inheritance of biallelic mutations in the MMR genes. Here we summarize the phenotype of individuals with inheritance of homozygous or compound heterozygous mutations in the MMR genes that result in a complete lack of protein or greatly compromised protein function. In contrast to individuals with Lynch syndrome I and II, individuals with no MMR function present with childhood onset of hematological and brain malignancies, whereas residual MMR function can also result in gastrointestinal cancers and an age of onset in the second to fourth decade. Individuals with biallelic MMR mutations often present with café-au-lait spots, regardless of the level of MMR function remaining. Thus, the inheritance of two MMR gene mutations is a separate entity from Lynch I or II or the subtypes Turcot and Muir-Torre.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539897     DOI: 10.1111/j.1399-0004.2007.00803.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  29 in total

1.  Rapid generation of rice mutants via the dominant negative suppression of the mismatch repair protein OsPMS1.

Authors:  Jie Xu; Meiru Li; Lei Chen; Guojiang Wu; Hongqing Li
Journal:  Theor Appl Genet       Date:  2012-06-12       Impact factor: 5.699

2.  Constitutional mismatch repair-deficiency syndrome.

Authors:  Katharina Wimmer; Christian P Kratz
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

3.  The predicted truncation from a cancer-associated variant of the MSH2 initiation codon alters activity of the MSH2-MSH6 mismatch repair complex.

Authors:  Jennifer L Cyr; Graham D Brown; Jennifer Stroop; Christopher D Heinen
Journal:  Mol Carcinog       Date:  2011-08-11       Impact factor: 4.784

Review 4.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 5.  DNA-damage repair; the good, the bad, and the ugly.

Authors:  Razqallah Hakem
Journal:  EMBO J       Date:  2008-02-20       Impact factor: 11.598

6.  The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.

Authors:  J Tinat; S Baert-Desurmont; J B Latouche; S Vasseur; C Martin; E Bouvignies; T Frébourg
Journal:  Fam Cancer       Date:  2008-05-22       Impact factor: 2.375

7.  Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein.

Authors:  Leah C Young; Kathleen M Bone; Peng Wang; Fang Wu; Benjamin A Adam; Samar Hegazy; Pascal Gelebart; Jelena Holovati; Liang Li; Susan E Andrew; Raymond Lai
Journal:  Am J Pathol       Date:  2011-05-24       Impact factor: 4.307

8.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

9.  Simultaneous colonic adenocarcinoma and medulloblastoma in a 12-year-old with biallelic deletions in PMS2.

Authors:  Holly Lindsay; Rima F Jubran; Larry Wang; Benjamin R Kipp; William A May
Journal:  J Pediatr       Date:  2013-04-10       Impact factor: 4.406

10.  The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.

Authors:  Raymond Lai; Robert J Ingham
Journal:  Ther Adv Hematol       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.